HEALTHMEDPAGE TODAY
Generic Single-Dose Flu Antiviral Gets FDA's Blessing
The FDA approved the first generic version of baloxavir marboxil (Xofluza) as a single-dose option to treat or prevent influenza in adults and children 5 years and older. The medication is approved for both treatment and prevention settings.
Related Signal
Adjacent reporting
- Ask Dr. Nandi: FDA approves 1st single-dose generic flu treatment ahead of flu season
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology
- Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine
- STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy